151 related articles for article (PubMed ID: 28527603)
1. Peritoneal tuberculosis in patients with rheumatoid arthritis undergoing adalimumab treatment.
Ortiz Balbuena J; Muñez Rubio E; Ramos Martínez A
Med Clin (Barc); 2017 Oct; 149(8):368. PubMed ID: 28527603
[No Abstract] [Full Text] [Related]
2. Tuberculous peritonitis after treatment with adalimumab.
Antolín J; Azahara M; Hernández C; Blanco M; Mao L; Cigüenza R
Scand J Infect Dis; 2008; 40(8):677-8. PubMed ID: 18979608
[TBL] [Abstract][Full Text] [Related]
3. New therapies, increased risk for old infections--abdominal tuberculosis mimicking colon cancer during adalimumab treatment for rheumatoid arthritis.
Dascalu C; Valceanu A; Brennessel D; Bandagi S
J Clin Rheumatol; 2013 Aug; 19(5):297-9. PubMed ID: 23884190
[No Abstract] [Full Text] [Related]
4. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
[No Abstract] [Full Text] [Related]
5. Peritoneal tuberculosis mimicking advanced ovarian cancer in a patient treated with methotrexate for chronic rheumatoid arthritis.
Huesler M; Ruef C; Pfyffer GE; Haller U; Fink D
J Obstet Gynaecol; 2003 May; 23(3):315-6. PubMed ID: 12850870
[No Abstract] [Full Text] [Related]
6. Infliximab for rheumatoid arthritis in a patient with tuberculosis.
Matsumoto T; Tanaka T; Kawase I
N Engl J Med; 2006 Aug; 355(7):740-1. PubMed ID: 16914717
[No Abstract] [Full Text] [Related]
7. [Meningeal and Guillain-Barrè syndrome in a patient with rheumatoid arthritis receiving adalimumab therapy].
López Méndez P; Martín Santana I; del Pino Reyes Yánez M; Ruano Hernández A; Hernández Beriain JÁ; Hervás García M
Reumatol Clin; 2011; 7(6):401-3. PubMed ID: 22078700
[TBL] [Abstract][Full Text] [Related]
8. Visceral Leishmaniasis among immunosuppressed patients with rheumatic diseases.
Erre GL; Mesina P; Tonelli N; Passiu G
Clin Exp Rheumatol; 2010; 28(4):590-1. PubMed ID: 20659417
[No Abstract] [Full Text] [Related]
9. Mycobacterium chelonae infection associated with adalimumab therapy.
Díaz F; Urkijo JC; Mendoza F; de la Viuda JM; Blanco M; Unzurrunzaga A; Ayarza R
Scand J Rheumatol; 2008; 37(2):159-60. PubMed ID: 18415777
[No Abstract] [Full Text] [Related]
10. Adalimumab biosimilar in rheumatoid arthritis: a total-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.
Mengato D; Messori A
Clin Exp Rheumatol; 2018; 36(6):1118. PubMed ID: 29600941
[No Abstract] [Full Text] [Related]
11. A case of peritoneal TB causing renal failure in a patient with rheumatoid arthritis and initial negative PPD after treatment with infliximab.
Sharma A; Dubey D; Janga K; Greenberg S
Ren Fail; 2014 Jul; 36(6):948-50. PubMed ID: 24960622
[TBL] [Abstract][Full Text] [Related]
12. Gastroparesis and ischemic gastric ulcers in a patient with rheumatoid arthritis receiving adalimumab therapy.
Ngamruengphong S; Zhai Q; Francis DL
Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):e35-6. PubMed ID: 25573493
[No Abstract] [Full Text] [Related]
13. Risk of developing active tuberculosis in rheumatoid arthritis patients on adalimumab in Japan.
Watanabe A; Matsumoto T; Igari H; Sawa J; Yamaguchi Y; Sakatani M
Int J Tuberc Lung Dis; 2016 Jan; 20(1):101-8. PubMed ID: 26688535
[TBL] [Abstract][Full Text] [Related]
14. Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review.
Downey C
Int J Rheum Dis; 2016 Jun; 19(6):536-50. PubMed ID: 26200188
[TBL] [Abstract][Full Text] [Related]
15. Development of Crescentic Immunoglobulin A Nephritis and Multiple Autoantibodies in a Patient during Adalimumab Treatment for Rheumatoid Arthritis.
Li X; Ma J; Zhao Y; Wang HY; Li XM
Chin Med J (Engl); 2015 Sep; 128(18):2555-6. PubMed ID: 26365982
[No Abstract] [Full Text] [Related]
16. Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents.
Furst DE; Cush J; Kaufmann S; Siegel J; Kurth R
Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii62-3. PubMed ID: 12379625
[No Abstract] [Full Text] [Related]
17. Pneumocystis Jirovecii Pneumonia in Japanese Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Pooled Analysis of 3 Agents.
Tanaka M; Sakai R; Koike R; Harigai M
J Rheumatol; 2015 Sep; 42(9):1726-8. PubMed ID: 26330129
[No Abstract] [Full Text] [Related]
18. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab.
Bassetti M; Pizzorni C; Gradoni L; Del Bono V; Cutolo M; Viscoli C
Rheumatology (Oxford); 2006 Nov; 45(11):1446-8. PubMed ID: 16887847
[No Abstract] [Full Text] [Related]
19. Cutaneous leishmaniasis: An opportunistic infection.
Moreno Martínez MJ; Moreno Ramos MJ; Sánchez Pedreño P
Reumatol Clin; 2017; 13(3):181-182. PubMed ID: 27642092
[No Abstract] [Full Text] [Related]
20. Tuberculous peritonitis.
Finlay DG; Szauter K; Raju GS; Snyder N
Am J Gastroenterol; 2005 Jul; 100(7):1624-5. PubMed ID: 15984997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
